amikacin has been researched along with Drug-Induced Cochlear Toxicity in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 6 (60.00) | 2.80 |
Authors | Studies |
---|---|
Ayral, M; Dedeoğlu, S | 1 |
Endo, A; Hanawa, K; Hanawa, T; Ishikawa, T; Kagami, Y; Katsumata, N; Kawano, Y; Kazama, S; Kobayashi, Y; Maebayashi, Y; Naito, A; Nemoto, A | 1 |
Szymański, M; Zadrożniak, M; Łuszczki, JJ | 1 |
Camci, ED; Gibson, RM; Kirkwood, NK; Kitcher, SR; Kros, CJ; Raible, DW; Redila, VA; Richardson, GP; Rubel, EW; Simon, JA; Wu, P | 1 |
Burt, RA; Lockhart, PJ; Ogier, JM | 1 |
Budhathoki, C; Dooley, KE; Dowdy, DW; Farley, JE; Francis, HW; Han, HR; Hong, H | 1 |
Fox, GJ; Ho, J; Redwood, L; Velen, K; Wrohan, I | 1 |
Brezun, JM; Cazals, Y; Edge, A; Lahlou, H; Lopez-Juarez, A; Ripoll, C; Wang, Q; Zine, A | 1 |
Admasu, A; Berha, AB; Negash, Z; Sheth, AN; Shibeshi, W; Yimer, G | 1 |
Aznar, ML; Brode, SK; Elshal, AS; Marras, TK; Mehrabi, M | 1 |
1 review(s) available for amikacin and Drug-Induced Cochlear Toxicity
Article | Year |
---|---|
Ototoxicity among multidrug-resistant TB patients: a systematic review and meta-analysis.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Humans; Ototoxicity; Tuberculosis, Multidrug-Resistant | 2021 |
9 other study(ies) available for amikacin and Drug-Induced Cochlear Toxicity
Article | Year |
---|---|
Protective effect of ethyl pyruvate on amikacin-induced ototoxicity in rats.
Topics: Amikacin; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Otoacoustic Emissions, Spontaneous; Ototoxicity; Pyruvates; Rats; Rats, Wistar | 2022 |
Evaluation of nephrotoxicity and ototoxicity following amikacin administration once daily or every 48 hours in neonates.
Topics: Amikacin; Anti-Bacterial Agents; Humans; Infant, Newborn; Kidney; Ototoxicity; Renal Insufficiency | 2022 |
N-Acetyl-L-cysteine Affects Ototoxicity Evoked by Amikacin and Furosemide Either Alone or in Combination in a Mouse Model of Hearing Threshold Decrease.
Topics: Acetylcysteine; Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Auditory Threshold; Deafness; Furosemide; Hearing; Hearing Loss; Mice; Ototoxicity | 2023 |
ORC-13661 protects sensory hair cells from aminoglycoside and cisplatin ototoxicity.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cell Culture Techniques; Cells, Cultured; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Hair Cells, Auditory; Humans; Intravital Microscopy; Ion Channels; Male; Mechanotransduction, Cellular; Mice; Ototoxicity; Patch-Clamp Techniques; Protective Agents; Rats; Thiophenes; Time-Lapse Imaging; Urea; Zebrafish | 2019 |
Intravenously delivered aminoglycoside antibiotics, tobramycin and amikacin, are not ototoxic in mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Drug Administration Schedule; Hearing; Hearing Loss; Injections, Intravenous; Kidney; Kidney Diseases; Mice, Inbred C57BL; Ototoxicity; Species Specificity; Time Factors; Tobramycin | 2020 |
Prevalence of Pre-Existing Hearing Loss Among Patients With Drug-Resistant Tuberculosis in South Africa.
Topics: Adolescent; Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Audiometry; Auditory Threshold; Cross-Sectional Studies; Female; Hearing Loss; HIV Infections; Humans; Hypoalbuminemia; Kanamycin; Male; Middle Aged; Ototoxicity; Prevalence; Renal Insufficiency; South Africa; Thinness; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Engraftment of Human Stem Cell-Derived Otic Progenitors in the Damaged Cochlea.
Topics: Amikacin; Animals; Auditory Threshold; Cell Differentiation; Cell Enlargement; Cell Movement; Cyclosporine; Disease Models, Animal; Fibroblast Growth Factor 10; Fibroblast Growth Factor 3; Guinea Pigs; Hair Cells, Auditory; Hearing Loss; Humans; Immunosuppressive Agents; Induced Pluripotent Stem Cells; Living Donors; Ototoxicity; Stem Cell Transplantation | 2019 |
Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study.
Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; Capreomycin; Child; Child, Preschool; Creatinine; Ethiopia; Female; HIV Infections; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged; Ototoxicity; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult | 2019 |
Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada.
Topics: Administration, Intravenous; Adult; Aged; Amikacin; Anti-Bacterial Agents; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Ontario; Ototoxicity; Retrospective Studies; Sputum; Treatment Outcome | 2019 |